Xun Shi

558 citations
27 papers · 361 indexed · h-index 10
Topics
Lung Cancer Treatments and Mutations (18 papers)Lung Cancer Diagnosis and Treatment (8 papers)Cancer Genomics and Diagnostics (8 papers)
Partner nations
ChinaUnited States

In The Last Decade

Xun Shi

23 papers receiving 359 citations

Peers

Xun Shi
Comparison fields: 5 of 41
  • Pulmonary and Respiratory Medicine 253
  • Oncology 231
  • Cancer Research 109
  • Molecular Biology 72
  • Pathology and Forensic Medicine 44
Replace Sebastian Michels with:
Sebastian Michels Germany
Kaiqi Du China
Analyn Lizaso China
Penelope Ann Bradbury Canada
Khémaies Slimane France
Nishi Kothari United States
Feiyu Niu China
Emily Roarty United States
N. Vardakis Greece
Kyoung-Mee Kim South Korea
Xun Shi relative to Sebastian Michels Germany Sebastian Michels's profile →
Citations per field
00.5×1.6×
Sebastian Michels · 1×
Citations per year

Countries citing papers authored by Xun Shi

Since Specialization
Citations

This map shows the geographic impact of Xun Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xun Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xun Shi more than expected).

Fields of papers citing papers by Xun Shi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xun Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xun Shi. The network helps show where Xun Shi may publish in the future.

Co-authorship network of co-authors of Xun Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Xun Shi. A scholar is included among the top collaborators of Xun Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xun Shi. Xun Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 2
3 0
4 2
5 0
6 7
7 3
8 0
9 20
10 33
11 75
12 48
13 15
14 11
15 5
16 55
17 13
18 7
19 2
20
[MRI in the evaluation of peripancreatic vessel invasion and resectability of pancreatic carcinoma].
1

About Xun Shi

Xun Shi is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research, having authored 27 papers that have together received 361 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (18 papers), Lung Cancer Diagnosis and Treatment (8 papers) and Cancer Genomics and Diagnostics (8 papers). The work is most often cited by research in Oncology (231 citations), Pulmonary and Respiratory Medicine (253 citations) and Cancer Research (109 citations). Xun Shi has collaborated with scholars based in China and United States. Frequent co-authors include Xinmin Yu, Ying Jin, Jun Zhao, Qiong He, Guangyuan Lou, Chen Lin, Zhengbo Song, Yiping Zhang, Yang Shao and Xue Wu. Their work appears in journals such as Journal of Clinical Oncology, British Journal of Cancer and Oncotarget.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026